Anupam Rasayan ETFA flow tech lifts efficiency 70% in 2026

What Anupam Rasayan announced

Anupam Rasayan India Ltd (NSE: ANURAS, BSE: 543275) said it has commercialised the production of ETFA (Ethyl trifluoroacetate) using its proprietary process-by-design continuous flow chemistry platform. The company described the move as a shift from conventional batch chemistry to a continuous flow model for this fluorinated building block. It also said the deployment is at commercial scale, not a lab or pilot demonstration. According to the company, this makes Anupam Rasayan the first company globally to manufacture ETFA at commercial scale using flow technology. The announcement places ETFA at the centre of the company’s technology positioning in custom synthesis and specialty chemicals.

Why ETFA matters for end markets

ETFA is described by the company as a critical intermediate for high-growth agrochemical and pharmaceutical markets. As a fluorinated building block, it is used in chemistry routes where handling reactivity and process safety can be key constraints. In that context, the company has positioned flow chemistry as an upgrade over batch processing. While Anupam Rasayan did not disclose customer names or volumes for ETFA, it linked the product’s relevance to life science value chains. The company operates in custom synthesis and specialty chemicals, supplying multinational customers across Europe, the US, and Japan, according to its corporate profile.

From batch to continuous flow: what changes in operations

The company said the ETFA process has moved from traditional batch processing to continuous flow chemistry. Flow chemistry typically means continuous raw material input and continuous product extraction, rather than discrete batch cycles. Anupam Rasayan stated that this approach improves safety when handling reactive fluorinated compounds compared with traditional batch methods. It also framed the change as a move toward higher capital efficiency and sustainability in specialty chemicals manufacturing. The company has previously highlighted its use of continuous processing and flow chemistry units alongside conventional reactors across facilities.

Efficiency and waste claims disclosed by the company

Anupam Rasayan said its flow chemistry process for ETFA is expected to improve manufacturing efficiency by 70% compared to traditional batch processes. It also stated that waste generation per metric tonne of ETFA produced could reduce by 30%. The company linked these improvements to the benefits of continuous production, including better process control and safer handling of reactive chemistry. In addition, it said lower energy costs are expected as part of the shift, although it did not quantify energy savings.

R&D timeline and commercial-scale deployment

The company said a two-year R&D cycle culminated in commercial-scale deployment of the ETFA flow chemistry process. It characterised this as a proprietary process-by-design platform, suggesting the process was developed internally rather than licensed. No further details were provided on commissioning dates, capacity dedicated to ETFA, or the specific plant location for the line. Still, the company’s framing indicates the technology is already in commercial operations rather than planned for a later start.

What the company indicated about margins

Anupam Rasayan said the technology could potentially lead to a 1.5% to 2% margin improvement for the ETFA product line over the next 12 months. This margin commentary was specifically tied to ETFA, not the company’s consolidated earnings. The company linked the margin impact to a combination of higher efficiency, lower waste, and lower energy costs. It did not provide a baseline margin for the ETFA line, nor did it disclose how much ETFA contributes to overall revenue.

Manufacturing footprint and recent capex points

In a separate management commentary included in the provided material, the company referenced completion of ₹670 crore of capex to create capacities in Gujarat across Sachin and Jhagadia. The same commentary also mentioned the acquisition of Tanfact as being aligned with building assets in India and supplying to global markets. The management commentary also included two points that were not reconciled in the excerpt: one reference to a foothold and a manufacturing facility in the US, and another statement that manufacturing is “100% in India.” The company operates multiple manufacturing sites in India and has listed Sachin, Gujarat, as its headquarters.

Key numbers at a glance

Market impact: what changes for investors and the sector

For investors tracking specialty chemicals, the announcement is mainly about process capability and execution rather than an immediate demand trigger. A 70% efficiency gain and a 30% waste reduction, if realised, could improve cost competitiveness for a fluorinated intermediate where yields, safety, and waste handling matter. The company’s stated 1.5% to 2% margin improvement for the ETFA line is a measurable outcome to watch, even though no ETFA revenue split was disclosed. The move also aligns with a broader industry push toward continuous manufacturing where it is technically feasible, particularly for complex chemistries and regulated end markets like agrochemicals and pharma.

Analysis: why the “commercial-scale flow” claim is notable

The key differentiator in this update is the “commercial scale” positioning and the claim of a global first for ETFA via flow technology. Flow chemistry has been adopted across parts of fine chemicals, but scaling fluorinated building blocks can be constrained by safety, material compatibility, and process control. By highlighting safety improvements for reactive fluorinated compounds, the company is signalling that its platform can handle demanding reactions with tighter control. The two-year R&D-to-commercialisation timeline also indicates a defined execution cycle, which matters for custom synthesis players where process innovation can be a source of pricing and stickier customer relationships.

Conclusion and what to track next

Anupam Rasayan’s ETFA commercialisation through continuous flow chemistry adds a clear technology milestone to its specialty chemicals narrative, backed by quantified efficiency, waste, and margin expectations. The next set of datapoints investors may look for are disclosures on ETFA volumes, customer ramp-up, and whether the margin improvement shows up in segment commentary over the next year. Any further clarity on manufacturing footprint, including how India and overseas facilities are utilised, would also help contextualise the scale of this product line within the broader business.